How do you manage HR+HER2 negative ILC metastatic recurrence in a post-menopausal woman with extensive GI involvement complicated by a small bowel obstruction?

Topics: Breast Cancer • Medical Oncology • MD Anderson • NCI-CCC Tumor Board Question • HR+ • NCI-CCC Breast Tumor Board Question • Breast Cancer, Metastatic

Patient was on tamoxifen when progression occurred; unable to tolerate adjuvant AI.

Answer from: Medical Oncologist at Community Practice

I think the answer to this question depends on a few factors. The management and outcome of patients with malignant bowel obstruction is described quite well by Tuca et al., PMID 22904637. The type of therapy I try would be influenced by their overall condition. Certainly, I would conside...

Comments

Medical Oncologist at Banner MD Anderson Cancer Center
I agree with Dr. @Jeffrey B. VanDeusen. In this ca...

Related Questions